Genetic polymorphism of sulfotransferase 1A1, cigarette smoking, hazardous chemical exposure and urothelial cancer risk in a Taiwanese population: Original article: Clinical investigation

International Journal of Urology

Volumn 15, Issue 12, 2008, Pages 1029-1034

  Wang, Yuan Hung ^a   Juang, Guang Dar ^b   Hwang, Thomas Is ^b   Shen, Cheng Huang ^c   Shao, Ke Yun ^a   Chiou, Hung Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Cigarette smoking; Genetic polymorphism; Hazardous chemicals; Sulfotransferase 1A1; Urothelial cancer

Indexed keywords

ARGININE; HISTIDINE; SULFOTRANSFERASE 1A1;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLADDER CANCER; CANCER RISK; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DANGEROUS GOODS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

AGED; ARYLSULFOTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; TAIWAN; UROLOGIC NEOPLASMS;

EID: 57449088403     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02166.x     Document Type: Article

References (33)

1. Bureau of Health Promotion, Department of Health, Taiwan ROC. Cancer Registry Annual Report, 2005 Cited 26 June 2008.] Available from URL: http://crs.cph.ntu.edu.tw/crs-c/annual.html
2. Samanic C, Kogevinas M, Dosemeci M et al. Smoking and bladder cancer in Spain: Effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol. Biomarkers Prev. 2006 15 : 1348 54.
3. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control. 2002 13 : 83 90.
4. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. WHO, Lyon, France, 1986.
5. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: The epidemiology of bladder cancer. Nat. Clin. Pract. Urol. 2006 3 : 327 40.
6. Kalble T Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer Urologe A 2001 40 : 447 50 In German E, Zeegers M, Paulussen A et al. Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett. 2007 245 : 51 60.
7. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001 10 : 89 94.
8. Nowell S, Falany CN. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 2006 25 : 1673 8.
9. Glatt H, Boeing H, Engelke CE et al. Human cytosolic sulphotransferases: Genetics, characteristics, toxicological aspects. Mutat. Res. 2001 482 : 27 40.
10. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chem. Biol. Interact. 2000 129 : 141 70.
11. Pereira WO, Paiva AS, Queiroz JW et al. Genetic polymorphism in the sulfotransferase SULT1A1 gene in cancer. Cancer Genet. Cytogenet. 2005 160 : 55 60.
12. Zheng L, Wang Y, Schabath MB, Grossman HB, Wu X. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: A case-control study. Cancer Lett. 2003 202 : 61 9.
13. Tang D, Rundle A, Mooney L et al. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res. Treat. 2003 78 : 217 22.
14. Tsukino H, Kuroda Y, Nakao H et al. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J. Cancer Res. Clin. Oncol. 2004 130 : 99 106.
15. Liang G, Miao X, Zhou Y, Tan W, Lin D. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 2004 25 : 773 8.
16. Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J. Urol. 2007 178 : 1196 200.
17. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M et al. Tobacco smoke and bladder cancer: In the European prospective investigation into cancer and nutrition. Int. J. Cancer 2006 119 : 2412 16.
18. Zeegers MP, Tan FE, Verhagen AP, Weijenberg MP, van den Brandt PA. Elevated risk of cancer of the urinary tract for alcohol drinkers: A meta-analysis. Cancer Causes Control. 1999 10 : 445 51.
19. Dryson E, Mannetje A, Walls C et al. Case-control study of high risk occupations for bladder cancer in New Zealand. Int. J. Cancer 2008 122 : 1340 6.
20. Zheng T, Cantor KP, Zhang Y, Lynch CF. Occupation and bladder cancer: A population-based, case-control study in Iowa. J. Occup. Environ. Med. 2002 44 : 685 91.
21. Hung RJ, Boffetta P, Brennan P et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer 2004 110 : 598 604.
22. Ozawa S, Katoh T, Inatomi H et al. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population. Int. J. Cancer 2002 102 : 418 21.
23. Han DF, Zhou X, Hu MB et al. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol. Lett. 2004 150 : 167 77.
24. Wong RH, Hu CW, Yeh CY et al. Sulfotransferase 1A1 and glutathione S-transferase P1 genetic polymorphisms modulate the levels of urinary 8-hydroxy-2′-deoxyguanosine in betel quid chewers. Arch. Toxicol. 2007 82 : 313 21. DOI 10.1007/s00204-007-0248-8.
25. Nowell S, Ratnasinghe DL, Ambrosone CB et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol. Biomarkers Prev. 2004 13 : 270 6.
26. Pachouri SS, Sobti RC, Kaur P, Singh J, Gupta SK. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. Cancer Genet. Cytogenet. 2006 171 : 39 43.
27. Tiemersma EW, Bunschoten A, Kok FJ, Glatt H, de Boer SY, Kampman E. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int. J. Cancer 2004 108 : 97 103.
28. Peng CT, Chen JC, Yeh KT et al. The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int. J. Mol Med. 2003 11 : 85 9.
29. Kim KA, Lee SY, Park PW et al. Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: Comparison of other ethnic groups. Eur. J. Clin. Pharmacol. 2005 61 : 743 7.
30. Pelucchi C, Negri E, Franceschi S, Talamini R, La Vecchia C. Alcohol drinking and bladder cancer. J. Clin. Epidemiol. 2002 55 : 637 41.
31. Djousse L, Schatzkin A, Chibnik LB, D'Agostino RB, Kreger BE, Ellison RC. Alcohol consumption and the risk of bladder cancer in the Framingham Heart Study. J. Natl. Cancer Inst. 2004 96 : 1397 400.
32. Hildebrandt MA, Carrington DP, Thomae BA et al. Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J. 2007 7 : 133 43.
33. Nagata K, Yamazoe Y. Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol. Toxicol. 2000 40 : 159 76.